FI970107L - Heterosyklisiä takykiniinireseptoriantagonisteja - Google Patents

Heterosyklisiä takykiniinireseptoriantagonisteja Download PDF

Info

Publication number: FI970107L
Authority: FI; Finland
Prior art keywords: heterocyclic; receptor antagonists; tachykinin receptor; tachykinin; antagonists
Prior art date: 1994-07-12

Application number

FI970107A

Other languages

English (en)

Swedish (sv)

Other versions

FI970107A7 (fi

FI970107A0 (fi

Inventor

Sung-Yong Stephen Cho

James Densmore Copp

Francis Orerenyo Ginah

Guy Joe Hansen

Philip Arthur Hipskind

Bret Eugene Huff

Michael John Martinelli

Michael Alexander Staszak

Roger William Tharp-Taylor

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-12

Filing date

1995-06-30

Publication date

1997-03-07

1995-06-30 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1997-01-10 Publication of FI970107A0 publication Critical patent/FI970107A0/fi

1997-03-07 Publication of FI970107A7 publication Critical patent/FI970107A7/fi

1997-03-07 Publication of FI970107L publication Critical patent/FI970107L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

FI970107A 1994-07-12 1995-06-30 Heterosyklisiä takykiniinireseptoriantagonisteja FI970107L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27170894A	1994-07-12	1994-07-12
PCT/US1995/008300 WO1996001819A1 (en)	1994-07-12	1995-06-30	Heterocyclic tachykinin receptor antagonists

Publications (3)

Publication Number	Publication Date
FI970107A0 FI970107A0 (fi)	1997-01-10
FI970107A7 FI970107A7 (fi)	1997-03-07
FI970107L true FI970107L (fi)	1997-03-07

Family

ID=23036729

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970107A FI970107L (fi)	1994-07-12	1995-06-30	Heterosyklisiä takykiniinireseptoriantagonisteja

Country Status (25)

Country	Link
US (1)	US5530009A (fi)
EP (1)	EP0693489B1 (fi)
JP (1)	JPH10502640A (fi)
CN (1)	CN1067067C (fi)
AT (1)	ATE205491T1 (fi)
AU (1)	AU688072B2 (fi)
BR (1)	BR9508375A (fi)
CA (1)	CA2194471C (fi)
CO (1)	CO4410196A1 (fi)
CZ (1)	CZ288434B6 (fi)
DE (1)	DE69522619T2 (fi)
DK (1)	DK0693489T3 (fi)
ES (1)	ES2163475T3 (fi)
FI (1)	FI970107L (fi)
HU (1)	HUT77948A (fi)
IL (1)	IL114474A (fi)
MX (1)	MX9700271A (fi)
NO (1)	NO309651B1 (fi)
NZ (1)	NZ289652A (fi)
PL (1)	PL180866B1 (fi)
PT (1)	PT693489E (fi)
RU (1)	RU2151769C1 (fi)
TR (1)	TR199500844A1 (fi)
WO (1)	WO1996001819A1 (fi)
ZA (1)	ZA955639B (fi)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403577B1 (en)	1993-11-17	2002-06-11	Eli Lilly And Company	Hexamethyleneiminyl tachykinin receptor antagonists
US6869957B1 (en)	1993-11-17	2005-03-22	Eli Lilly And Company	Non-peptide tachykinin receptor antagonists
WO1996041631A1 (en) *	1995-06-09	1996-12-27	Eli Lilly And Company	Methods of treating cold and allergic rhinitis
ZA966891B (en) *	1995-08-21	1998-02-16	Lilly Co Eli	2-acylaminopropanamines as growth hormone secretagogues.
WO1997023455A1 (en) *	1995-12-21	1997-07-03	Eli Lilly And Company	Processes for preparing non-peptidyl tachykinin receptor antagonists
CA2247822A1 (en) *	1996-03-11	1997-09-18	Smriti Iyengar	Methods of treating or preventing interstitial cystitis
US6239144B1 (en)	1997-04-03	2001-05-29	Eli Lilly And Company	Methods of treating bone loss
AU7580998A (en) *	1997-05-21	1998-12-11	Eli Lilly And Company	3-arylpropylamino neuropeptide y receptor antagonists
HRP20000065A2 (en) *	1997-08-06	2001-04-30	Lilly Co Eli	2-acylaminopropanamines as tachykinin receptor antagonists
PL338456A1 (en)	1997-08-06	2000-11-06	Lilly Co Eli	2-acylaminopropanoamines as antagonists of the tachykinin receptor
GB2333785B (en)	1998-01-28	2002-07-31	Baker Hughes Inc	Remote actuation of downhole tools using vibration
GB9816897D0 (en) *	1998-08-04	1998-09-30	Merck Sharp & Dohme	Therapeutic use
RU2309953C2 (ru)	1999-11-03	2007-11-10	Эймр Текнолоджи, Инк.	Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
GB9927125D0 (en)	1999-11-16	2000-01-12	Univ Reading The	Placental human neurokinin B precursor
WO2002004455A2 (en)	2000-07-11	2002-01-17	Albany Molecular Research, Inc	4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
WO2003101459A1 (en) *	2002-05-29	2003-12-11	The Regents Of The University Of California	Antagonizing nk1 receptors inhibits consumption of substances of abuse
US7541357B2 (en)	2004-07-15	2009-06-02	Amr Technology, Inc.	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
DE602006016244D1 (de)	2005-03-08	2010-09-30	Janssen Pharmaceutica Nv	Diazaspiro-ä4,4ü-nonanderivate als neurokinin-(nk1)-antagonisten
EP1888050B1 (en)	2005-05-17	2012-03-21	Merck Sharp & Dohme Ltd.	cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid for the treatment of cancer
JP5258561B2 (ja)	2005-07-15	2013-08-07	アルバニーモレキュラーリサーチ，インコーポレイテッド	アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
EP2109608B1 (en)	2007-01-10	2011-03-23	Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A.	Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
US8389553B2 (en)	2007-06-27	2013-03-05	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es)	2008-06-04	2010-07-28	Bristol Myers Squibb Co	Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
WO2010114780A1 (en)	2009-04-01	2010-10-07	Merck Sharp & Dohme Corp.	Inhibitors of akt activity
DK2429296T3 (en)	2009-05-12	2018-03-12	Albany Molecular Res Inc	7 - ([1,2,4,] TRIAZOLO [1,5, -A] PYRIDIN-6-YL) -4- (3,4-DICHLORPHENYL) -1,2,3,4- TETRAHYDROISOQUINOLINE AND USE thereof
KR20120034644A (ko)	2009-05-12	2012-04-12	알바니 몰레큘라 리써치, 인크.	아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
EP2429293B1 (en)	2009-05-12	2014-10-29	Bristol-Myers Squibb Company	CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
BR112012008849A2 (pt)	2009-10-14	2015-09-22	Schering Corp	composto, composição farmacêutica, e, uso de um composto
EP2601293B1 (en)	2010-08-02	2017-12-06	Sirna Therapeutics, Inc.	RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
JP2013537423A (ja)	2010-08-17	2013-10-03	メルク・シャープ・エンド・ドーム・コーポレイション	低分子干渉核酸（ｓｉＮＡ）を用いたＢ型肝炎ウイルス（ＨＢＶ）遺伝子発現のＲＮＡ干渉媒介性阻害
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en)	2010-09-01	2012-03-08	Schering Corporation	Indazole derivatives useful as erk inhibitors
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
WO2012058210A1 (en)	2010-10-29	2012-05-03	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
WO2012087772A1 (en)	2010-12-21	2012-06-28	Schering Corporation	Indazole derivatives useful as erk inhibitors
CN103732592A (zh)	2011-04-21	2014-04-16	默沙东公司	胰岛素样生长因子-1受体抑制剂
US9023865B2 (en)	2011-10-27	2015-05-05	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
US20150299696A1 (en)	2012-05-02	2015-10-22	Sirna Therapeutics, Inc.	SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
EP2900241B1 (en)	2012-09-28	2018-08-08	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
AU2013352568B2 (en)	2012-11-28	2019-09-19	Merck Sharp & Dohme Llc	Compositions and methods for treating cancer
TW201429969A (zh)	2012-12-20	2014-08-01	Merck Sharp & Dohme	作爲ｈｄｍ２抑制劑之經取代咪唑吡啶
EP2951180B1 (en)	2013-01-30	2018-05-02	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as hdm2 inhibitors
EP3041938A1 (en)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Circular polynucleotides
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
WO2019094312A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3706742B1 (en)	2017-11-08	2023-03-15	Merck Sharp & Dohme LLC	Prmt5 inhibitors
WO2020033284A1 (en)	2018-08-07	2020-02-13	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
BR112021002267A8 (pt)	2018-08-07	2023-02-07	Merck Sharp & Dohme	Inibidores de prmt5
WO2020033282A1 (en)	2018-08-07	2020-02-13	Merck Sharp & Dohme Corp.	Prmt5 inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3367985D1 (en) *	1982-09-18	1987-01-15	Lillywhites Cantabrian Ltd	Display unit
US5331089A (en)	1988-03-25	1994-07-19	Merck Sharpe & Dohme, Ltd.	Peptides useful as tachykinin agonists
US5182282A (en) *	1989-04-28	1993-01-26	Roussel Uclaf	4-Benzyl-1H-indole derivatives
IL99320A (en) *	1990-09-05	1995-07-31	Sanofi Sa	Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676055B1 (fr) *	1991-05-03	1993-09-03	Sanofi Elf	Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676053B1 (fr) *	1991-05-03	1993-08-27	Sanofi Elf	Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2110514A1 (en)	1991-07-05	1993-01-21	Raymond Baker	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
EP1082959A1 (en)	1991-09-20	2001-03-14	Glaxo Group Limited	NK1 Antagonists for the treatment of depression
US5328927A (en)	1992-03-03	1994-07-12	Merck Sharpe & Dohme, Ltd.	Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
US5444074A (en) *	1992-04-15	1995-08-22	Merck Sharp & Dohme Limited	Piperidine tachykinin receptor antagonists
AU4713293A (en)	1992-07-13	1994-01-31	Merck Sharp & Dohme Limited	Heterocyclic amide derivatives as tachykinin derivatives
DK0655055T3 (da)	1992-08-13	2001-01-02	Warner Lambert Co	Tachykininantagonister
FR2696178B1 (fr)	1992-09-30	1994-12-30	Sanofi Elf	Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5344830A (en)	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
US5418242A (en) *	1993-05-18	1995-05-23	Laboratoires Upsa	Piperidinylthioindole derivatives, their methods of preparation and pharmaceutical compositions in which they are present, useful especially as analgesics
EP0686629A3 (en) *	1994-06-10	1999-02-10	Eli Lilly And Company	Cyclohexyl tachykinine receptor antagonists

1995
- 1995-06-30 NZ NZ289652A patent/NZ289652A/en unknown
- 1995-06-30 CA CA002194471A patent/CA2194471C/en not_active Expired - Fee Related
- 1995-06-30 CN CN95194996A patent/CN1067067C/zh not_active Expired - Fee Related
- 1995-06-30 BR BR9508375A patent/BR9508375A/pt not_active Application Discontinuation
- 1995-06-30 WO PCT/US1995/008300 patent/WO1996001819A1/en not_active Ceased
- 1995-06-30 JP JP8504355A patent/JPH10502640A/ja not_active Ceased
- 1995-06-30 PL PL95318327A patent/PL180866B1/pl unknown
- 1995-06-30 FI FI970107A patent/FI970107L/fi unknown
- 1995-06-30 MX MX9700271A patent/MX9700271A/es unknown
- 1995-06-30 CZ CZ199757A patent/CZ288434B6/cs not_active IP Right Cessation
- 1995-06-30 RU RU97102050/04A patent/RU2151769C1/ru active
- 1995-06-30 HU HU9700069A patent/HUT77948A/hu unknown
- 1995-06-30 AU AU29560/95A patent/AU688072B2/en not_active Ceased
- 1995-07-06 ZA ZA955639A patent/ZA955639B/xx unknown
- 1995-07-06 IL IL11447495A patent/IL114474A/xx not_active IP Right Cessation
- 1995-07-07 ES ES95304750T patent/ES2163475T3/es not_active Expired - Lifetime
- 1995-07-07 DK DK95304750T patent/DK0693489T3/da active
- 1995-07-07 DE DE69522619T patent/DE69522619T2/de not_active Expired - Fee Related
- 1995-07-07 PT PT95304750T patent/PT693489E/pt unknown
- 1995-07-07 AT AT95304750T patent/ATE205491T1/de not_active IP Right Cessation
- 1995-07-07 EP EP95304750A patent/EP0693489B1/en not_active Expired - Lifetime
- 1995-07-10 CO CO95029998A patent/CO4410196A1/es unknown
- 1995-07-11 TR TR95/00844A patent/TR199500844A1/xx unknown
1996
- 1996-06-05 US US08/462,413 patent/US5530009A/en not_active Expired - Fee Related
1997
- 1997-01-09 NO NO970078A patent/NO309651B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0693489B1 (en)	2001-09-12
CN1067067C (zh)	2001-06-13
IL114474A0 (en)	1995-11-27
NO970078L (no)	1997-01-09
MX9700271A (es)	1997-05-31
BR9508375A (pt)	1997-10-28
NZ289652A (en)	1998-05-27
FI970107A7 (fi)	1997-03-07
AU688072B2 (en)	1998-03-05
DE69522619T2 (de)	2002-06-27
WO1996001819A1 (en)	1996-01-25
ATE205491T1 (de)	2001-09-15
HU9700069D0 (en)	1997-02-28
CZ5797A3 (en)	1997-04-16
CO4410196A1 (es)	1997-01-09
CN1157615A (zh)	1997-08-20
JPH10502640A (ja)	1998-03-10
ES2163475T3 (es)	2002-02-01
FI970107A0 (fi)	1997-01-10
NO970078D0 (no)	1997-01-09
CA2194471A1 (en)	1996-01-25
PT693489E (pt)	2002-01-30
ZA955639B (en)	1997-01-06
AU2956095A (en)	1996-02-09
EP0693489A1 (en)	1996-01-24
HUT77948A (hu)	1998-12-28
CA2194471C (en)	2005-04-12
DE69522619D1 (de)	2001-10-18
TR199500844A1 (tr)	1996-10-21
NO309651B1 (no)	2001-03-05
IL114474A (en)	1999-12-31
US5530009A (en)	1996-06-25
PL180866B1 (pl)	2001-04-30
DK0693489T3 (da)	2001-11-12
PL318327A1 (en)	1997-06-09
CZ288434B6 (en)	2001-06-13
RU2151769C1 (ru)	2000-06-27

Publication	Publication Date	Title
FI970107L (fi)	1997-03-07	Heterosyklisiä takykiniinireseptoriantagonisteja
NO951613D0 (no)	1995-04-27	Ikke-peptidyl tachykinin reseptorantagonister
DE69734833D1 (de)	2006-01-12	Vitronektin rezeptor antagonisten
NO972016D0 (no)	1997-04-30	Indolyl-Y-reseptorantagonister
NO972526D0 (no)	1997-06-03	Tachykininantagonister
FI964712L (fi)	1997-01-23	Kinoliinijohdannaisia takykiniini NK3-reseptoriantagonisteina
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
NO965608D0 (no)	1996-12-27	Vitronectin-reseptor-antagonister
EP0866705A4 (en)	1999-03-03	FIBRINOGENIC RECEPTOR ANTAGONISTS
FI962489A7 (fi)	1996-08-13	Morfoliini-ja tiomoforfoliinitakykiniinireseptoriantaginisteja
FI962074A7 (fi)	1996-05-15	Takykiniinireseptorin ei-peptidi-antagonisteja
FI955223L (fi)	1996-05-03	Adheesioreseptoriantagonisteja
ID16742A (id)	1997-11-06	Antagonis reseptor endotelin
FI960516L (fi)	1996-08-07	Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
DK0906294T3 (da)	2003-05-05	Benzoxazinon-dopamin D4-receptor-antagonister
FI953916L (fi)	1995-08-21	Fibrinogeenireseptoriantagonisteja
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
EP0929218A4 (en)	2001-05-16	P2Y RECEPTOR ANTAGONISTS
FI955351L (fi)	1996-05-09	Tarttumisreseptoriantagonistit
ID24468A (id)	2000-07-20	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
NO179550C (no)	1996-10-30	Tachykinin reseptorantagonister
DE69732715D1 (de)	2005-04-14	Tachykinin antagoniste
ID24309A (id)	2000-07-13	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID22978A (id)	1999-12-23	Antagonis reseptor endotelin